Could Lab-Grown eye cells restore sight? new trial begins
NCT ID NCT03957954
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether stem cells grown from a patient's own eye can be safely transplanted to repair the cornea in people with limbal stem cell deficiency, a condition that causes vision loss. Twenty adults with severe vision loss will receive the transplant, and researchers will monitor for side effects like infection and check if the cells successfully grow on the eye. The goal is to see if the procedure is safe and feasible before moving to larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Lab-grown stem cells may restore damaged eye surfaces
- 500-Patient study aims to map rare eye Disease's natural course
- New eye drops aim to repair cornea damage in rare vision disorder
- Scientists hunt for genes behind worst cases of rare eye condition
- Scientists hunt for biomarkers to unlock rare eye disease treatments
- Eye membrane patch shows promise for blinding corneal disease